CCL4 and Sepsis: Firstly, we observed that in experimental sepsis-induced secondary S. aureus pneumonia, recombinant CCL4 could improve lung pathology and lung injury, increase the clearance rate of bacteria from the lungs and blood, and effectively promote macrophage recruitment in the lungs and reduce mortality (Figures 5(a)–5(i)).